Quantcast
Last updated on April 16, 2014 at 12:11 EDT

Latest Harrisvaccines Stories

2014-01-30 16:26:00

AMES, Iowa, Jan. 30, 2014 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) autogenous licensure of the company's Rotavirus C vaccine utilizing its SirraVax(SM )RNA Particle Technology, approved by the Department's Center for Veterinary Biologics (CVB) for disease caused by Rotavirus subtype C. Rotavirus C is a cause of diarrhea and mortality in young piglets. Preparing effective...

2013-10-29 08:32:22

AMES, Iowa, Oct. 29, 2013 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has expanded its exclusive license agreement with AlphaVax, Inc. to include all companion animals diseases, in addition to all livestock animal diseases (swine, cattle, horses, poultry, and farmed aquatic animals). Today's announcement significantly expands the Harrisvaccines product portfolio, transforming it from a primarily production livestock-focused company to a...

2013-10-01 12:23:08

AMES, Iowa, Oct. 1, 2013 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been awarded a grant from the USDA National Institute of Food and Agriculture (NIFA) for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) research. This project is supported by Agriculture and Food Research Initiative Grant no. 2013-67015-21307 from the USDA National Institute of Food and Agriculture. The grant, titled Proteomics-defined Porcine...

2012-09-20 06:31:34

AMES, Iowa, Sept. 20, 2012 /PRNewswire/ -- Harrisvaccines announces United States Department of Agriculture (USDA) licensure of the company's swine flu vaccine, approved by the Department's Center for Veterinary Biologics (CVB) for disease caused by swine influenza virus (SIV) H3N2. The vaccine is the first to be licensed by the USDA CVB that utilizes RNA Particle Technology. Dr. Kurt Kamrud, Vice President of Research and Chief Scientific Officer at Harrisvaccines, led the...